University Hospital, Geneva: Communicable Diseases trials

The registry lists 13 Communicable Diseases studies with University Hospital, Geneva as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)RecruitingNCT06998251
• Study of the Efficacy of Plain Soap and Water Versus Alcohol-based Rubs for Surgical Hand PreparationCompletedNCT00987402Phase 1/2Results posted
• Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational StudyCompletedNCT05794412
• Outcomes in Hospitalized Older Patients With COVID-19CompletedNCT04385212
• DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant RecipientsCompletedNCT03642977
• Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular InfectionsCompletedNCT03602209Not applicable
• Prevalence of HPV Infection Using Self-samplingCompletedNCT03474211
• Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious KeratitisCompletedNCT02717871Phase 3
• Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) InfectionCompletedNCT00711854Phase 4
• Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical PatientsCompletedNCT00685867Not applicable
• Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsCompletedNCT00448604
• Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.Status unknownNCT00150852Phase 2
• Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV InfectionCompletedNCT00113126Not applicable